haloperidol has been researched along with Disseminated Intravascular Coagulation in 4 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| "We observed a case of NMS in which disseminated intravascular coagulation was a prominent feature." | 1.27 | Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation. ( DiPette, DJ; Eles, GR; Songer, JE, 1984) |
| "ARDS and disseminated intravascular coagulation may be important, atypical signs encountered early in NMS and complicating its recognition." | 1.27 | Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation. ( Baxter, JW; Johnson, MD; Newman, JH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russell, T | 1 |
| Riazi, S | 1 |
| Kraeva, N | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Eles, GR | 1 |
| Songer, JE | 1 |
| DiPette, DJ | 1 |
| Seki, Y | 1 |
| Takahashi, H | 1 |
| Aizawa, Y | 1 |
| Johnson, MD | 1 |
| Newman, JH | 1 |
| Baxter, JW | 1 |
4 other studies available for haloperidol and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.
Topics: Adult; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Disseminated Intravascular Coagula | 1984 |
[Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Blood Coagulation; Blood Coagula | 1998 |
Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation.
Topics: Diagnosis, Differential; Disseminated Intravascular Coagulation; Haloperidol; Humans; Male; Middle A | 1988 |